Literature DB >> 12759438

Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48.

Samira Muñoz1, Rogelio Hernández-Pando, Soman N Abraham, Jose Antonio Enciso.   

Abstract

Mast cells (MC) are abundant in the lung and other peripheral tissue, where they participate in inflammatory processes against bacterial infections. Like other effector cells of the innate immune system, MC interact directly with a wide variety of infectious agents. This interaction results in MC activation and inflammatory mediator release. We demonstrated that MC interact with Mycobacterium tuberculosis, triggering the release of several prestored reagents, such as histamine and beta-hexosaminidase, and de novo synthesized cytokines, such as TNF-alpha and IL-6. A number of M. tuberculosis Ags, ESAT-6, MTSA-10, and MPT-63, have been implicated in MC activation and mediator release. A MC plasmalemmal protein, CD48, was implicated in interactions with mycobacteria because CD48 appeared to aggregate in the MC membrane at sites of bacterial binding and because Abs to CD48 inhibited the MC histamine response to mycobacteria. Cumulatively, these findings suggest that MC, even in the absence of opsonins, can directly recognize M. tuberculosis and its Ags and have the potential to play an active role in mediating the host's innate response to M. tuberculosis infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759438     DOI: 10.4049/jimmunol.170.11.5590

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

Review 1.  Mast cell mediator responses and their suppression by pathogenic and commensal microorganisms.

Authors:  Hae Woong Choi; Soman N Abraham
Journal:  Mol Immunol       Date:  2014-03-11       Impact factor: 4.407

Review 2.  Plasticity in mast cell responses during bacterial infections.

Authors:  Cheryl Y Chan; Ashley L St John; Soman N Abraham
Journal:  Curr Opin Microbiol       Date:  2011-11-04       Impact factor: 7.934

3.  Transcriptome Analysis of Mycobacteria-Specific CD4+ T Cells Identified by Activation-Induced Expression of CD154.

Authors:  Shajo Kunnath-Velayudhan; Michael F Goldberg; Neeraj K Saini; Christopher T Johndrow; Tony W Ng; Alison J Johnson; Jiayong Xu; John Chan; William R Jacobs; Steven A Porcelli
Journal:  J Immunol       Date:  2017-08-18       Impact factor: 5.422

Review 4.  The impact of bacterial infection on mast cell degranulation.

Authors:  Jordan Wesolowski; Fabienne Paumet
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

5.  Human mast cells synthesize and release angiogenin, a member of the ribonuclease A (RNase A) superfamily.

Authors:  Marianna Kulka; Nobuyuki Fukuishi; Dean D Metcalfe
Journal:  J Leukoc Biol       Date:  2009-07-22       Impact factor: 4.962

Review 6.  Key role of mast cells and their major secretory products in inflammatory bowel disease.

Authors:  Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

7.  Histamine plays an essential regulatory role in lung inflammation and protective immunity in the acute phase of Mycobacterium tuberculosis infection.

Authors:  D Carlos; C Fremond; A Samarina; V Vasseur; I Maillet; S G Ramos; F Erard; V Quesniaux; H Ohtsu; C L Silva; L H Faccioli; B Ryffel
Journal:  Infect Immun       Date:  2009-10-12       Impact factor: 3.441

8.  Escherichia coli exposure inhibits exocytic SNARE-mediated membrane fusion in mast cells.

Authors:  Jordan Wesolowski; Fabienne Paumet
Journal:  Traffic       Date:  2014-03-07       Impact factor: 6.215

Review 9.  Mast cells: multitalented facilitators of protection against bacterial pathogens.

Authors:  Nikita H Trivedi; M Neal Guentzel; Annette R Rodriguez; Jieh-Juen Yu; Thomas G Forsthuber; Bernard P Arulanandam
Journal:  Expert Rev Clin Immunol       Date:  2013-02       Impact factor: 4.473

Review 10.  Role of nitric oxide in mast cells: controversies, current knowledge, and future applications.

Authors:  Yokananth Sekar; Tae Chul Moon; Samira Muñoz; A Dean Befus
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.